首頁(yè)
瀏覽量: 195
- 產(chǎn)品名稱(chēng)： Research Grade Navicixizumab ( 那賽昔珠單抗 )
- 產(chǎn)品貨號(hào)： CSD00427
- 貨期： 現(xiàn)貨
- 價(jià)格與訂購(gòu)： 2480
- 數(shù)量：
庫(kù)存： 100
- 規(guī)格： 100μg
- 產(chǎn)品信息
- 如何訂購(gòu)
貨號(hào)（Catalog No.）
CSD00427
通用名INN
Navicixizumab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Navicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).
別名(Alternative names)
OMP-305B83
靶點(diǎn);物種(Specificity target name;species)
DLL4/VEGFA[Homo sapiens]
種類(lèi)(Species)
Chimeric,Humanized
受體鑒定(Receptor identification)
IgG2-kappa
分子量(MV)
148000.00 Da
CAS
1638338-43-8
存儲(chǔ)條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產(chǎn)品銷(xiāo)售：
E - mail ：
郵 編：
Amily
